SVOPL
geneOn this page
Also known as MGC46715SLC22B5
Summary
SVOPL (SVOP like, HGNC:27034) is a protein-coding gene on chromosome 7q34, encoding Putative transporter SVOPL (Q8N434).
The protein encoded by this gene is thought to be a member of solute carrier family 22, which includes transmembrane proteins that transport toxins and drugs from the body. This gene is a paralog of the SVOP gene that encodes synaptic vesicle 2-related protein.
Source: NCBI Gene 136306 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 132 total
- MANE Select transcript:
NM_001139456
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27034 |
| Approved symbol | SVOPL |
| Name | SVOP like |
| Location | 7q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC46715, SLC22B5 |
| Ensembl gene | ENSG00000157703 |
| Ensembl biotype | protein_coding |
| OMIM | 611700 |
| Entrez | 136306 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000288513, ENST00000419765, ENST00000421622, ENST00000436657, ENST00000441685, ENST00000463557, ENST00000478865, ENST00000674285, ENST00000867898
RefSeq mRNA: 3 — MANE Select: NM_001139456
NM_001139456, NM_001331192, NM_174959
CCDS: CCDS47721, CCDS5848
Canonical transcript exons
ENST00000674285 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001034447 | 138628158 | 138628363 |
| ENSE00001034450 | 138630049 | 138630122 |
| ENSE00001228445 | 138627350 | 138627461 |
| ENSE00001599945 | 138672019 | 138672117 |
| ENSE00001691762 | 138678434 | 138678525 |
| ENSE00001779079 | 138678964 | 138679079 |
| ENSE00001794219 | 138659864 | 138659988 |
| ENSE00003501735 | 138596417 | 138596530 |
| ENSE00003505724 | 138649012 | 138649137 |
| ENSE00003509934 | 138594285 | 138594621 |
| ENSE00003517519 | 138656448 | 138656511 |
| ENSE00003528606 | 138621046 | 138621135 |
| ENSE00003556847 | 138663074 | 138663145 |
| ENSE00003612865 | 138644717 | 138644845 |
| ENSE00003690140 | 138625969 | 138626050 |
| ENSE00003898478 | 138701178 | 138701362 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 98.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.8415 / max 205.4147, expressed in 63 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86448 | 0.5049 | 51 |
| 86449 | 0.2705 | 34 |
| 86450 | 0.0661 | 21 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 98.97 | gold quality |
| oocyte | CL:0000023 | 98.92 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 86.97 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 76.97 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 76.37 | silver quality |
| metanephros cortex | UBERON:0010533 | 75.06 | gold quality |
| minor salivary gland | UBERON:0001830 | 66.46 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 65.82 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 65.33 | gold quality |
| metanephros | UBERON:0000081 | 64.84 | gold quality |
| right uterine tube | UBERON:0001302 | 64.49 | gold quality |
| right adrenal gland | UBERON:0001233 | 64.41 | gold quality |
| left adrenal gland | UBERON:0001234 | 63.53 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 63.35 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 63.19 | gold quality |
| mouth mucosa | UBERON:0003729 | 63.08 | gold quality |
| bronchial epithelial cell | CL:0002328 | 62.21 | silver quality |
| adrenal cortex | UBERON:0001235 | 62.12 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 61.67 | gold quality |
| bronchus | UBERON:0002185 | 61.39 | silver quality |
| adrenal gland | UBERON:0002369 | 60.89 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 59.99 | silver quality |
| adenohypophysis | UBERON:0002196 | 57.61 | gold quality |
| pituitary gland | UBERON:0000007 | 57.28 | gold quality |
| cortex of kidney | UBERON:0001225 | 56.72 | gold quality |
| kidney | UBERON:0002113 | 56.38 | gold quality |
| left testis | UBERON:0004533 | 56.09 | gold quality |
| caudate nucleus | UBERON:0001873 | 56.05 | gold quality |
| right testis | UBERON:0004534 | 55.85 | gold quality |
| testis | UBERON:0000473 | 55.22 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 13.14 |
| E-MTAB-10042 | yes | 8.81 |
| E-MTAB-8410 | yes | 8.74 |
| E-HCAD-10 | yes | 7.27 |
| E-ANND-3 | yes | 5.34 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting SVOPL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-5689 | 99.50 | 71.26 | 1154 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-12135 | 98.99 | 70.26 | 1814 |
| HSA-MIR-4326 | 98.97 | 67.63 | 962 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-299-5P | 98.56 | 71.14 | 1140 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
| HSA-MIR-548AX | 98.55 | 69.58 | 1362 |
| HSA-MIR-532-5P | 98.43 | 67.53 | 760 |
| HSA-MIR-6529-5P | 97.85 | 66.47 | 673 |
| HSA-MIR-379-5P | 97.52 | 67.81 | 485 |
| HSA-MIR-3529-5P | 97.12 | 67.06 | 440 |
| HSA-MIR-4633-5P | 96.17 | 66.36 | 501 |
Cross-species orthologs
43 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | svopl | ENSDARG00000057983 |
| mus_musculus | Svopl | ENSMUSG00000029830 |
| rattus_norvegicus | Svopl | ENSRNOG00000013378 |
| drosophila_melanogaster | Orct | FBGN0019952 |
| drosophila_melanogaster | CG15221 | FBGN0030331 |
| drosophila_melanogaster | Balat | FBGN0033778 |
| drosophila_melanogaster | CG5592 | FBGN0035645 |
| drosophila_melanogaster | CG10486 | FBGN0035647 |
| drosophila_melanogaster | CG14691 | FBGN0037829 |
| drosophila_melanogaster | CG14855 | FBGN0038260 |
| drosophila_melanogaster | CG14856 | FBGN0038261 |
| drosophila_melanogaster | CG14857 | FBGN0038262 |
| drosophila_melanogaster | CG12783 | FBGN0038448 |
| drosophila_melanogaster | CG7333 | FBGN0038715 |
| drosophila_melanogaster | CG7342 | FBGN0038716 |
| drosophila_melanogaster | CG17751 | FBGN0038717 |
| drosophila_melanogaster | CG17752 | FBGN0038718 |
| drosophila_melanogaster | CG16727 | FBGN0038719 |
| drosophila_melanogaster | CG6231 | FBGN0038720 |
| drosophila_melanogaster | CG4465 | FBGN0038750 |
| drosophila_melanogaster | CG4462 | FBGN0038752 |
| drosophila_melanogaster | CG4459 | FBGN0038753 |
| drosophila_melanogaster | CG6356 | FBGN0039178 |
| drosophila_melanogaster | CG3690 | FBGN0040350 |
| drosophila_melanogaster | CG31103 | FBGN0051103 |
| drosophila_melanogaster | CG31106 | FBGN0051106 |
| drosophila_melanogaster | CG31272 | FBGN0051272 |
| drosophila_melanogaster | CG33233 | FBGN0053233 |
| drosophila_melanogaster | CG33234 | FBGN0053234 |
| drosophila_melanogaster | Orct2 | FBGN0086365 |
| drosophila_melanogaster | CG42269 | FBGN0259164 |
| drosophila_melanogaster | CG44098 | FBGN0264907 |
| caenorhabditis_elegans | WBGENE00003837 | |
| caenorhabditis_elegans | oct-1 | WBGENE00003842 |
| caenorhabditis_elegans | WBGENE00003843 | |
| caenorhabditis_elegans | WBGENE00006220 | |
| caenorhabditis_elegans | WBGENE00008110 | |
| caenorhabditis_elegans | WBGENE00011456 | |
| caenorhabditis_elegans | WBGENE00014127 | |
| caenorhabditis_elegans | WBGENE00017751 | |
| caenorhabditis_elegans | WBGENE00019408 | |
| caenorhabditis_elegans | WBGENE00020701 | |
| caenorhabditis_elegans | WBGENE00044455 |
Paralogs (22): SLC22A16 (ENSG00000004809), SLC22A17 (ENSG00000092096), SLC22A2 (ENSG00000112499), SLC22A7 (ENSG00000137204), SLC22A23 (ENSG00000137266), SLC22A14 (ENSG00000144671), SLC22A3 (ENSG00000146477), SLC22A8 (ENSG00000149452), SLC22A9 (ENSG00000149742), SLC22A15 (ENSG00000163393), SVOP (ENSG00000166111), SLC22A11 (ENSG00000168065), SLC22A13 (ENSG00000172940), SLC22A1 (ENSG00000175003), SLC22A10 (ENSG00000184999), SLC22A25 (ENSG00000196600), SLC22A4 (ENSG00000197208), SLC22A5 (ENSG00000197375), SLC22A24 (ENSG00000197658), SLC22A12 (ENSG00000197891), SLC22A6 (ENSG00000197901), SLC22A31 (ENSG00000259803)
Protein
Protein identifiers
Putative transporter SVOPL — Q8N434 (reviewed: Q8N434)
Alternative names: SV2-related protein-like, SVOP-like protein
All UniProt accessions (4): A0A6I8PL26, C9JVJ9, Q8N434, F8WES3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the major facilitator superfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N434-1 | 1 | yes |
| Q8N434-2 | 2 |
RefSeq proteins (3): NP_001132928, NP_001318121, NP_777619 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005828 | MFS_sugar_transport-like | Family |
| IPR011701 | MFS | Family |
| IPR020846 | MFS_dom | Domain |
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
Pfam: PF00083, PF07690
UniProt features (14 total): transmembrane region 10, splice variant 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N434-F1 | 84.29 | 0.54 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOBP_TRANSMEMBRANE_TRANSPORT, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOMF_TRANSPORTER_ACTIVITY, GREB1_TARGET_GENES, HAND1_TARGET_GENES, PAX3_TARGET_GENES, MIR12123, MIR4326, MIR532_5P, GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP, CIZ_01, GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS, HAY_BONE_MARROW_CD34_POS_MEP, DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS, DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS
GO Biological Process (1): transmembrane transport (GO:0055085)
GO Molecular Function (2): transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
786 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SVOPL | SLC67A2 | Q8NBP5 | 708 |
| SVOPL | SLC75A1 | Q14728 | 665 |
| SVOPL | MFSD11 | O43934 | 640 |
| SVOPL | UNC93A | Q86WB7 | 637 |
| SVOPL | SLC61A1 | Q6N075 | 627 |
| SVOPL | COQ9 | O75208 | 623 |
| SVOPL | NAT9 | Q9BTE0 | 614 |
| SVOPL | LRGUK | Q96M69 | 572 |
| SVOPL | SPNS3 | Q6ZMD2 | 570 |
| SVOPL | SLC68A1 | Q14CX5 | 534 |
| SVOPL | HPS3 | Q969F9 | 530 |
| SVOPL | RAD51AP1 | Q96B01 | 522 |
| SVOPL | SLC71A1 | Q96MC6 | 517 |
| SVOPL | SLC33A2 | Q96ES6 | 512 |
| SVOPL | R3HCC1 | Q9Y3T6 | 510 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IQCB1 | PCP4L1 | psi-mi:“MI:0914”(association) | 0.350 |
| SVOPL | RTN2 | psi-mi:“MI:0914”(association) | 0.350 |
| SVOPL | PSMD12 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (43): SVOPL (Affinity Capture-MS), TMEM42 (Two-hybrid), PCP4 (Affinity Capture-MS), SERPINE2 (Affinity Capture-MS), LMF2 (Affinity Capture-MS), RTN2 (Affinity Capture-MS), SIDT2 (Affinity Capture-MS), RTN4 (Affinity Capture-MS), C4orf32 (Affinity Capture-MS), AHNAK (Affinity Capture-MS), AMOT (Affinity Capture-MS), ARFGAP3 (Affinity Capture-MS), ASCC3 (Affinity Capture-MS), ATXN2 (Affinity Capture-MS), BAG6 (Affinity Capture-MS)
ESM2 similar proteins: A1L1W9, B0JZE1, D3Z5L6, D4A9K4, F1NJ67, G5E8K6, G8XYX6, O08966, O15375, O35308, O35440, O60669, O70324, O70451, O70461, O94956, P36021, P53985, P53986, P53987, P53988, Q03064, Q05B81, Q0IHM1, Q3MHW6, Q3U9N9, Q5EBA8, Q5TF39, Q63089, Q63344, Q68F72, Q6DCX5, Q6DEJ6, Q6NT16, Q6PDF3, Q6PEM8, Q7ZWG6, Q80T22, Q8BH31, Q8CE47
Diamond homologs: A4QH18, P07661, P0A2G3, P0A2G4, P0AEX3, P0AEX4, P0C0L7, P0C0L8, P0DPR5, P16482, P37643, P40862, P44610, P44699, P76350, P77228, Q47421, Q4L3Q4, Q5HIA2, Q5HRH0, Q6GBR4, Q6GJ96, Q79VC4, Q7A771, Q8N434, Q8NXW9, Q99W36, Q9KWK6, A0A1E3B0S4, O52733, O59726, P11636, P30605, P30638, Q0P4G6, Q1JP63, Q1LVS8, Q28ES4, Q2XWK0, Q4F7G0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
132 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 108 |
| Likely benign | 9 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2604 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:138621133:GACC:G | acceptor_loss | 1.0000 |
| 7:138621134:ACCT:A | acceptor_loss | 1.0000 |
| 7:138621136:C:CA | acceptor_loss | 1.0000 |
| 7:138621137:T:C | acceptor_loss | 1.0000 |
| 7:138625962:AACTC:A | donor_loss | 1.0000 |
| 7:138625963:ACTC:A | donor_loss | 1.0000 |
| 7:138625966:CACC:C | donor_loss | 1.0000 |
| 7:138625967:A:AC | donor_gain | 1.0000 |
| 7:138625968:C:CA | donor_loss | 1.0000 |
| 7:138625968:C:CC | donor_gain | 1.0000 |
| 7:138625968:CCT:C | donor_gain | 1.0000 |
| 7:138626046:CGGCA:C | acceptor_gain | 1.0000 |
| 7:138626047:GGCA:G | acceptor_gain | 1.0000 |
| 7:138626048:GCA:G | acceptor_gain | 1.0000 |
| 7:138626048:GCACT:G | acceptor_loss | 1.0000 |
| 7:138626049:CA:C | acceptor_gain | 1.0000 |
| 7:138626049:CAC:C | acceptor_gain | 1.0000 |
| 7:138626049:CACT:C | acceptor_loss | 1.0000 |
| 7:138626050:AC:A | acceptor_loss | 1.0000 |
| 7:138626051:C:CC | acceptor_gain | 1.0000 |
| 7:138626051:CTAGA:C | acceptor_loss | 1.0000 |
| 7:138626052:T:A | acceptor_loss | 1.0000 |
| 7:138628153:CTTA:C | donor_loss | 1.0000 |
| 7:138628154:TTA:T | donor_loss | 1.0000 |
| 7:138628155:TA:T | donor_loss | 1.0000 |
| 7:138628156:A:AC | donor_gain | 1.0000 |
| 7:138628156:ACAAG:A | donor_gain | 1.0000 |
| 7:138628157:C:CT | donor_gain | 1.0000 |
| 7:138628157:CA:C | donor_gain | 1.0000 |
| 7:138628157:CAA:C | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000006050 (7:138632726 A>AGGATGGGGGC), RS1000019503 (7:138642016 C>T), RS1000044598 (7:138670063 C>T), RS1000044720 (7:138626241 G>A), RS1000050144 (7:138676905 T>A), RS1000054472 (7:138647627 G>A), RS1000188432 (7:138698773 A>G), RS1000191019 (7:138693639 G>A,C), RS1000197208 (7:138620957 C>T), RS1000206676 (7:138604139 T>G), RS1000285876 (7:138631196 T>A), RS1000286075 (7:138665219 C>T), RS1000294716 (7:138679700 G>A), RS1000347388 (7:138679435 A>G), RS1000350568 (7:138615109 G>A)
Disease associations
OMIM: gene MIM:611700 | disease phenotypes: MIM:236750
GenCC curated gene-disease
Mondo (1): non-immune hydrops fetalis (MONDO:0009369)
Orphanet (1): Non-immune hydrops fetalis (Orphanet:363999)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006088_53 | Familial squamous cell lung carcinoma | 5.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006953 | family history of lung cancer |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| entinostat | increases expression, affects cotreatment | 2 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| pentanal | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Bortezomib | decreases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Cyclosporine | increases methylation | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4UW | HuH7-SVOPL-KO-c2 | Cancer cell line | Male |
| CVCL_D4UX | HuH7-SVOPL-KO-c3 | Cancer cell line | Male |
Clinical trials (associated diseases)
2 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04308603 | Not specified | COMPLETED | Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing |
| NCT05528796 | Not specified | ENROLLING_BY_INVITATION | Uncovering the Etiologies of Non-immune Hydrops Fetalis |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): non-immune hydrops fetalis